Criteria of validity for animal models of psychiatric disorders: focus on anxiety disorders and depression

Animal models of psychiatric disorders are usually discussed with regard to three criteria first elaborated by Willner; face, predictive and construct validity. Here, we draw the history of these concepts and then try to redraw and refine these criteria, using the framework of the diathesis model of depression that has been proposed by several authors. We thus propose a set of five major criteria (with sub-categories for some of them); homological validity (including species validity and strain validity), pathogenic validity (including ontopathogenic validity and triggering validity), mechanistic validity, face validity (including ethological and biomarker validity) and predictive validity (including induction and remission validity). Homological validity requires that an adequate species and strain be chosen: considering species validity, primates will be considered to have a higher score than drosophila, and considering strains, a high stress reactivity in a strain scores higher than a low stress reactivity in another strain. Pathological validity corresponds to the fact that, in order to shape pathological characteristics, the organism has been manipulated both during the developmental period (for example, maternal separation: ontopathogenic validity) and during adulthood (for example, stress: triggering validity). Mechanistic validity corresponds to the fact that the cognitive (for example, cognitive bias) or biological mechanisms (such as dysfunction of the hormonal stress axis regulation) underlying the disorder are identical in both humans and animals. Face validity corresponds to the observable behavioral (ethological validity) or biological (biomarker validity) outcomes: for example anhedonic behavior (ethological validity) or elevated corticosterone (biomarker validity). Finally, predictive validity corresponds to the identity of the relationship between the triggering factor and the outcome (induction validity) and between the effects of the treatments on the two organisms (remission validity). The relevance of this framework is then discussed regarding various animal models of depression.

[1]  W. Bunney,et al.  Animal model of depression. I. Review of evidence: implications for research. , 1969, Archives of general psychiatry.

[2]  E. Zerhouni.  US biomedical research: basic, translational, and clinical sciences. , 2005, JAMA.

[3]  J. John Mann,et al.  Antidepressants increase neural progenitor cells in the human hippocampus , 2009, Neuropsychopharmacology.

[4]  J. A. Boer,et al.  Handbook of depression and anxiety , 2003 .

[5]  The Effect of “Parental Loss” under 18 on Developing “MDD” in Adult Age , 2007, International journal of psychiatry in medicine.

[6]  A. Damjanović,et al.  [Animal models of depression]. , 2000, Vojnosanitetski pregled.

[7]  R. Hen,et al.  Drug-Dependent Requirement of Hippocampal Neurogenesis in a Model of Depression and of Antidepressant Reversal , 2008, Biological Psychiatry.

[8]  G. Gutiérrez-Ospina,et al.  Periodic maternal separation decreases hippocampal neurogenesis without affecting basal corticosterone during the stress hyporesponsive period, but alters HPA axis and coping behavior in adulthood , 2012, Psychoneuroendocrinology.

[9]  Dan J Stein,et al.  Animal models of anxiety disorders , 2003, Current psychiatry reports.

[10]  C. Hommet,et al.  Olfaction: A potential cognitive marker of psychiatric disorders , 2008, Neuroscience & Biobehavioral Reviews.

[11]  L. Price,et al.  Childhood Parental Loss and Adult Psychopathology: Effects of Loss Characteristics and Contextual Factors , 2008, International journal of psychiatry in medicine.

[12]  Animal models of depression: a diathesis/stress approach , 2003 .

[13]  R. Hen,et al.  Antidepressants recruit new neurons to improve stress response regulation , 2011, Molecular Psychiatry.

[14]  L. Cronbach,et al.  Construct validity in psychological tests. , 1955, Psychological bulletin.

[15]  N. Singewald,et al.  The clinical implications of mouse models of enhanced anxiety. , 2011, Future neurology.

[16]  Rachel A. Millstein,et al.  Early life genetic, epigenetic and environmental factors shaping emotionality in rodents , 2005, Neuroscience & Biobehavioral Reviews.

[17]  C. Belzung,et al.  The design of new antidepressants: can formal models help? A first attempt using a model of the hippocampal control over the HPA-axis based on a review from the literature , 2010, Behavioural pharmacology.

[18]  T. Robbins,et al.  Translating cognition from animals to humans. , 2011, Biochemical pharmacology.

[19]  I. Lucki,et al.  Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. Mcarthur,et al.  PREFACE: What Do You Mean by “Translational Research”? An Enquiry Through Animal and Translational Models for CNS Drug Discovery: Reward Deficit Disorders , 2008 .

[21]  J. Knight,et al.  ANIMAL BEHAVIOR AND DRUG ACTION , 1965 .

[22]  F. J. van der Staay,et al.  Animal models of behavioral dysfunctions: basic concepts and classifications, and an evaluation strategy. , 2006, Brain research reviews.

[23]  C. Beevers,et al.  Neural mechanisms of the cognitive model of depression , 2011, Nature Reviews Neuroscience.

[24]  Jason S. Snyder,et al.  Adult hippocampal neurogenesis buffers stress responses and depressive behavior , 2011, Nature.

[25]  F. V. D. Staay,et al.  Animal models of behavioral dysfunctions: Basic concepts and classifications, and an evaluation strategy , 2006, Brain Research Reviews.

[26]  P. Philippot,et al.  Anxiety from a Phylogenetic Perspective: Is there a Qualitative Difference between Human and Animal Anxiety? , 2007, Neural plasticity.

[27]  A. Kalueff.  Animal models in biological psychiatry , 2006 .

[28]  J. Eriksson,et al.  Depressive symptoms in adults separated from their parents as children: a natural experiment during World War II. , 2007, American journal of epidemiology.

[29]  T. Robbins.  Homology in behavioural pharmacology: an approach to animal models of human cognition. , 1998, Behavioural pharmacology.

[30]  D. Noll,et al.  Impact of chronic hypercortisolemia on affective processing , 2012, Neuropharmacology.

[31]  D. Overstreet,et al.  The Flinders Sensitive Line rat: A selectively bred putative animal model of depression , 2005, Neuroscience & Biobehavioral Reviews.

[32]  S. Arndt,et al.  Evaluation of animal models of neurobehavioral disorders , 2008, Behavioral and Brain Functions.

[33]  L. Klimek,et al.  Characteristics of olfactory disorders in relation to major causes of olfactory loss. , 2002, Archives of otolaryngology--head & neck surgery.

[34]  F. Bloom,et al.  Psychopharmacology: The Fourth Generation of Progress , 1995 .

[35]  F. A. Schroeder,et al.  Antidepressant-Like Effects of the Histone Deacetylase Inhibitor, Sodium Butyrate, in the Mouse , 2007, Biological Psychiatry.

[36]  E. Aronica,et al.  Decreased numbers of progenitor cells but no response to antidepressant drugs in the hippocampus of elderly depressed patients , 2010, Neuropharmacology.

[37]  D. Treit,et al.  Animal models of anxiety and anxiolytic drug action. , 2010, Current topics in behavioral neurosciences.

[38]  S. Hyman,et al.  Animal models of neuropsychiatric disorders , 2010, Nature Neuroscience.

[39]  G. Koob,et al.  Animal models of psychiatric disorders. , 2012, Handbook of clinical neurology.

[40]  P. Willner,et al.  The validity of animal models of depression , 2004, Psychopharmacology.

[41]  G. Glover,et al.  Dissociated neural representations of intensity and valence in human olfaction , 2003, Nature Neuroscience.

[42]  N. Varney,et al.  Psychopharmacology: The Fourth Generation of Progress. , 1996 .

[43]  L. Price,et al.  Childhood Parental Loss and Adult Hypothalamic-Pituitary-Adrenal Function , 2008, Biological Psychiatry.

[44]  S. Arndt,et al.  Evaluation of animal models of neurobehavioral disorders , 2009, Behavioral and Brain Functions.

[45]  C. Nemeroff,et al.  The American Psychiatric Press Textbook of Psychopharmacology , 1995 .

[46]  R. Hen,et al.  Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants , 2003, Science.

[47]  D. Campbell,et al.  EXPERIMENTAL AND QUASI-EXPERIMENT Al DESIGNS FOR RESEARCH , 2012 .

[48]  M. Drew,et al.  Neurogenesis-Dependent and -Independent Effects of Fluoxetine in an Animal Model of Anxiety/Depression , 2009, Neuron.

[49]  Scott J. Russo,et al.  Molecular Adaptations Underlying Susceptibility and Resistance to Social Defeat in Brain Reward Regions , 2007, Cell.

[50]  J. Cryan,et al.  The age of anxiety: role of animal models of anxiolytic action in drug discovery , 2011, British journal of pharmacology.

[51]  J. Maser,et al.  Psychopathology : experimental models , 1977 .

[52]  D. Schteingart,et al.  Depressed Mood and Other Psychiatric Manifestations of Cushing's Syndrome: Relationship to Hormone Levels , 1981, Psychosomatic medicine.

[53]  E. Seifritz,et al.  Helplessness: a systematic translational review of theory and evidence for its relevance to understanding and treating depression. , 2011, Pharmacology & therapeutics.

[54]  S. Mann,et al.  Ciba Foundation Symposium , 1997 .

[55]  V. Camus,et al.  Olfactory anhedonia and negative olfactory alliesthesia in depressed patients , 2010, Psychiatry Research.